| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.13 | 0.03 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.04 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.099 | 0.06 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.06 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.058 | 0.06 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.097 | 0.07 |